Management of acne induced by JAK inhibitors

被引：8
作者：
Correia, Catarina [1 ]
Antunes, Joana [1 ,2 ]
Filipe, Paulo [1 ,2 ]
机构：
[1] Ctr Hosp Univ Lisboa Norte CHULN, Hosp Santa Maria, Dermatol Dept, Lisbon, Portugal
[2] Univ Lisbon, Fac Med, Lisbon, Portugal
来源：
DERMATOLOGIC THERAPY | 2022年 / 35卷 / 09期
关键词：
DOUBLE-BLIND; PLACEBO; UPADACITINIB; ADOLESCENTS; ADULTS;
D O I：
10.1111/dth.15688
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页数：2
相关论文
共 8 条
  • [1] Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis
    Bieber, Thomas
    Simpson, Eric L.
    Silverberg, Jonathan I.
    Thaci, Diamant
    Paul, Carle
    Pink, Andrew E.
    Kataoka, Yoko
    Chu, Chia-Yu
    DiBonaventura, Marco
    Rojo, Ricardo
    Antinew, Jeremias
    Ionita, Ileana
    Sinclair, Rodney
    Forman, Seth
    Zdybski, Jacek
    Biswas, Pinaki
    Malhotra, Bimal
    Zhang, Fan
    Valdez, Hernan
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (12) : 1101 - 1112
  • [2] Safety considerations of systemic Janus kinase inhibitors in atopic dermatitis applications
    Chang, Po-Hsiung
    Huang, Sheng-Fen
    Chang, Po-Sheng
    Yu, Yu
    [J]. JOURNAL OF DERMATOLOGY, 2021, 48 (11) : 1631 - 1639
  • [3] Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double- blind, randomised controlled phase 3 trials
    Guttman-Yassky, Emma
    Teixeira, Henrique D.
    Simpson, Eric L.
    Papp, Kim A.
    Pangan, Aileen L.
    Blauvelt, Andrew
    Thaci, Diamant
    Chu, Chia-Yu
    Hong, H. Chih-Ho
    Katoh, Norito
    Paller, Amy S.
    Calimlim, Brian
    Gu, Yihua
    Hu, Xiaofei
    Liu, Meng
    Yang, Yang
    Liu, John
    Tenorio, Allan R.
    Chu, Alvina D.
    Irvine, Alan D.
    [J]. LANCET, 2021, 397 (10290) : 2151 - 2168
  • [4] European evidence-based (S3) guideline for the treatment of acne - update 2016-short version
    Nast, A.
    Dreno, B.
    Bettoli, V.
    Mokos, Z. Bukvic
    Degitz, K.
    Dressler, C.
    Finlay, A. Y.
    Haedersdal, M.
    Lambert, J.
    Layton, A.
    Lomholt, H. B.
    Lopez-Estebaranz, J. L.
    Ochsendorf, F.
    Oprica, C.
    Rosumeck, S.
    Simonart, T.
    Werner, R. N.
    Gollnick, H.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 (08) : 1261 - 1268
  • [5] Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial
    Reich, Kristian
    Teixeira, Henrique D.
    de Bruin-Weller, Marjolein
    Bieber, Thomas
    Soong, Weily
    Kabashima, Kenji
    Werfel, Thomas
    Zeng, Jiewei
    Huang, Xiaohong
    Hu, Xiaofei
    Hendrickson, Barbara A.
    Ladizinski, Barry
    Chu, Alvina D.
    Silverberg, Jonathan I.
    [J]. LANCET, 2021, 397 (10290) : 2169 - 2181
  • [6] Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis A Randomized Clinical Trial
    Reich, Kristian
    Kabashima, Kenji
    Peris, Ketty
    Silverberg, Jonathan, I
    Eichenfield, Lawrence F.
    Bieber, Thomas
    Kaszuba, Aleksandra
    Kolodsick, Jill
    Yang, Fan E.
    Gamalo, Margaret
    Brinker, Dennis R.
    Delozier, Amy M.
    Janes, Jonathan M.
    Nunes, Fabio P.
    Thyssen, Jacob P.
    Simpson, Eric L.
    [J]. JAMA DERMATOLOGY, 2020, 156 (12) : 1333 - 1343
  • [7] JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
    Schwartz, Daniella M.
    Kanno, Yuka
    Villarino, Alejandro
    Ward, Michael
    Gadina, Massimo
    O'Shea, John J.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2017, 16 (12) : 843 - 862
  • [8] Safety of Janus kinase (JAK) inhibitors in the short-term treatment of atopic dermatitis
    Wood, Hannah
    Chandler, Antoinette
    Nezamololama, Novin
    Papp, Kim
    Gooderham, Melinda J.
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2022, 61 (06) : 746 - 754
1